Nanobiotix S.A. (NBTX) Discusses on New Phase 1 Results In Metastatic Melanoma Conference (NASDAQ:NBTX) 2025-09-18

Group 1 - The company is responsible for the development of transcript-related projects [1] - The company publishes thousands of quarterly earnings calls per quarter [1] - The company is continuing to grow and expand its coverage [1]